HYDROXYPROGESTERONE CAPROATE

NDC auxiliary status#

Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded package	package	55150-310	55150-310-01	D	Discontinued by firm		2026-07-31

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
55150-310-01	ML - Milliliter	55150-310	3f135ae5-0c76-4cb9-a4ec-420ecd4e6953	1	2019-06-19

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
276F2O42F5	HYDROXYPROGESTERONE CAPROATE	630-56-8	HYDROXYPROGESTERONE CAPROATE

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
55150-310-01	55150031001	1 VIAL, MULTI-DOSE in 1 CARTON (55150-310-01) > 5 mL in 1 VIAL, MULTI-DOSE	2019-04-16	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
HYDROXYPROGESTERONE CAPROATE	AuroMedics Pharma LLC \| EUGIA Pharma Specialities Limited	2019-09-27	Human Prescription Drug Label	2